HONG KONG, July 7, 2026 /PRNewswire/ -- The HKSH Cancer Centre under HKSH Medical Group (HKSH) introduced proton therapy in 2023, covering a wide range of cancer types including breast, prostate as ...

Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first ...

An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.

Recent advances in prostate cancer radiotherapy have prioritized techniques that minimize treatment-related toxicity and ...

Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...

People assigned female at birth can get a rare type of cancer called Skene’s gland cancer, similar to prostate cancer. People with this type of cancer can have a range of urinary symptoms as well as ...

About the Center of Excellence This collection includes articles developed with the oversight of the expert Advisory Board to provide current clinical recommendations and guidance for the entire care ...